Directors of biotechnology firm XenoPort Inc. voted in a preferred share purchase plan in mid-December. It was the last poison pill installed by an American firm in 2005. (c) 2006 Mergers and Acquisitions Journal and SourceMedia, Inc. All Rights Reserved. http://www.majournal.com http://www.sourcemedia.com
To read the entire story, you must be logged in.
Please log in now or register with us.
